BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26856845)

  • 1. Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance.
    Allan RN; Morgan S; Brito-Mutunayagam S; Skipp P; Feelisch M; Hayes SM; Hellier W; Clarke SC; Stoodley P; Burgess A; Ismail-Koch H; Salib RJ; Webb JS; Faust SN; Hall-Stoodley L
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2456-66. PubMed ID: 26856845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalosporin-NO-donor prodrug PYRRO-C3D shows β-lactam-mediated activity against Streptococcus pneumoniae biofilms.
    Allan RN; Kelso MJ; Rineh A; Yepuri NR; Feelisch M; Soren O; Brito-Mutunayagam S; Salib RJ; Stoodley P; Clarke SC; Webb JS; Hall-Stoodley L; Faust SN
    Nitric Oxide; 2017 May; 65():43-49. PubMed ID: 28235635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Small Molecule DAM Inhibitor, Pyrimidinedione, Disrupts Streptococcus pneumoniae Biofilm Growth In Vitro.
    Yadav MK; Go YY; Chae SW; Song JJ
    PLoS One; 2015; 10(10):e0139238. PubMed ID: 26431532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a Biofilm-Disrupting Nontypeable
    Bailey MT; Lauber CL; Novotny LA; Goodman SD; Bakaletz LO
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32295873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Photodynamic Therapy with Chlorin e6 Is Bactericidal against Biofilms of the Primary Human Otopathogens.
    Luke-Marshall NR; Hansen LA; Shafirstein G; Campagnari AA
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669474
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic modulation of mucins in otitis media; should this change our approach to watchful waiting?
    Hong W; Khampang P; Kerschner AR; Mackinnon AC; Yan K; Simpson PM; Kerschner JE
    Int J Pediatr Otorhinolaryngol; 2019 Oct; 125():134-140. PubMed ID: 31302575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
    Barraud N; Hassett DJ; Hwang SH; Rice SA; Kjelleberg S; Webb JS
    J Bacteriol; 2006 Nov; 188(21):7344-53. PubMed ID: 17050922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility.
    Hoberman A; Paradise JL; Block S; Burch DJ; Jacobs MR; Balanescu MI
    Pediatr Infect Dis J; 1996 Oct; 15(10):955-62. PubMed ID: 8895940
    [No Abstract]   [Full Text] [Related]  

  • 11. Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution.
    Dagan R; Leibovitz E; Greenberg D; Bakaletz L; Givon-Lavi N
    J Infect Dis; 2013 Oct; 208(7):1152-60. PubMed ID: 23842949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates.
    Hall-Stoodley L; Nistico L; Sambanthamoorthy K; Dice B; Nguyen D; Mershon WJ; Johnson C; Hu FZ; Stoodley P; Ehrlich GD; Post JC
    BMC Microbiol; 2008 Oct; 8():173. PubMed ID: 18842140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution, dynamics and antibiotic resistance patterns of Streptococcus pneumoniae serotypes causing acute otitis media in children in southern Israel during the 10 year-period before the introduction of the 7-valent pneumococcal conjugate vaccine.
    Somech I; Dagan R; Givon-Lavi N; Porat N; Raiz S; Leiberman A; Puterman M; Peled N; Greenberg D; Leibovitz E
    Vaccine; 2011 Jun; 29(25):4202-9. PubMed ID: 21497634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo.
    Perez AC; Pang B; King LB; Tan L; Murrah KA; Reimche JL; Wren JT; Richardson SH; Ghandi U; Swords WE
    Pathog Dis; 2014 Apr; 70(3):280-8. PubMed ID: 24391058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production.
    Sanchez CJ; Kumar N; Lizcano A; Shivshankar P; Dunning Hotopp JC; Jorgensen JH; Tettelin H; Orihuela CJ
    PLoS One; 2011; 6(12):e28738. PubMed ID: 22174882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of Antibiotic-Resistant Nonvaccine-Type Pneumococcal Clones to Cause Otitis Media in an Infant Mouse Model of Pneumococcal-Influenza Virus Coinfection.
    Frazão N; Hermans P; van Selm S; Sá-Leão R; de Lencastre H; Tomasz A; Diavatopoulos D
    Microb Drug Resist; 2016 Jan; 22(1):97-101. PubMed ID: 26366835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.
    Kempf M; Varon E; Lepoutre A; Gravet A; Baraduc R; Brun M; Chardon H; Cremniter J; Croizé J; Dalmay F; Demachy MC; Fosse T; Grelaud C; Hadou T; Hamdad F; Koeck JL; Luce S; Mermond S; Patry I; Péchinot A; Raymond J; Ros A; Segonds C; Soullié B; Tandé D; Vergnaud M; Vernet-Garnier V; Wallet F; Gutmann L; Ploy MC; Lanotte P
    Clin Microbiol Infect; 2015 Jan; 21(1):35-42. PubMed ID: 25636925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms.
    Vandevelde NM; Tulkens PM; Muccioli GG; Van Bambeke F
    J Antimicrob Chemother; 2015; 70(6):1713-26. PubMed ID: 25712316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone.
    McEllistrem MC; Ransford JV; Khan SA
    J Clin Microbiol; 2007 Jan; 45(1):97-101. PubMed ID: 17093036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.
    Isla A; Trocóniz IF; Canut A; Labora A; Martín-Herrero JE; Pedraz JL; Gascón AR
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):167-73. PubMed ID: 21334779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.